The Need to Rebuild Trust in Vaccines with Measle Cases on the Rise

A concerning influx of measles in the United States is a reminder of the need to restore public trust in vaccines. Vaccines and broader preventive healthcare are critical for combating illnesses and diseases. When trust in these measures diminishes, preventable diseases rise, which is increasingly evident in part of the U.S.

As of May 16, 2024, 139 measles cases have been reported across 21 jurisdictions. This year has seen 10 outbreaks, 70% of the cases being outbreak-associated. In comparison, 2023 had four outbreaks, with 48% of the cases linked to outbreaks. The current cases involve many young children, with 45% under five years old, 22% aged 5–19, and 32% aged 20 and older. The vaccination status of the infected shows that 82% were unvaccinated or had unknown vaccination status, 13% had received one dose of the MMR vaccine, and 6% had received two doses.

Globally, The World Health Organization (WHO) reported 40 times more cases across 41 European countries in 2023 compared to 2022. Cases nearly doubled from 2022 to 2023, with 2024 figures projected to be even worse.

Understanding the Measles Resurgence

Measles is a highly infectious viral disease that can lead to severe health complications, including pneumonia, encephalitis, and even death. The United States declared measles eliminated in 2000, thanks to the widespread use of the measles, mumps, and rubella (MMR) vaccine. However, the recent outbreaks reveal gaps in vaccine coverage, often linked to misinformation and skepticism about vaccines.

Several factors contribute to the current situation:

  1. Misinformation and Disinformation: The increase of false information about vaccines, particularly through social media, has significantly fueled vaccine hesitancy. Misleading claims about vaccine safety and efficacy have sown doubt and fear, deterring some parents from vaccinating their children.
  2. Complacency: Due to the past success of vaccination programs, many people have forgotten the dangers of vaccine-preventable diseases. This complacency leads to lower vaccination rates, creating pockets where outbreaks can occur.
  3. Distrust in Institutions: A growing distrust in government and health institutions has made some individuals skeptical of public health recommendations, including vaccinations. Political polarization and varying opinions on health regulations can exacerbate this distrust.

Strategies to Rebuild Trust

Restoring public confidence in vaccination is a complex task. However, various strategies have been proposed to address vaccine hesitancy and concerns involving medical associations, the pharmaceutical industry, and local, national, and international health authorities. Key strategies include providing valid information transparently, emphasizing the scientific evaluation and safety protocols surrounding vaccines, and engaging in international collaborations to monitor and address vaccine confidence issues. Additionally, leveraging media, including social media, to disseminate accurate information and counter misinformation is crucial. Improving healthcare provider preparedness through training on vaccine-related knowledge and communication skills and providing support and resources is essential in building trustful relationships with patients and parents.

The Broader Impact of Vaccines

Vaccination serves dual purposes; it protects individuals from infectious diseases while allowing communities to create immunity. As mentioned above, 70% of the measles cases found this year were outbreak-associated. By staying informed about what’s happening in your community and keeping up with an immunization schedule, people can extend protection to those who cannot be vaccinated and help alleviate pressure on medical facilities.

With spring in full swing and summer right around the corner, Health officials at the CDC and American Medical Association are urging individuals and their families to vaccinate against measles and help eliminate this disease once again.

Source

CDC: Measle Cases and Outbreaks

National Library of Medicine: Vaccine confidence: the keys to restoring trust

WHO: Measles

Pew Research Center: Americans’ Trust in Scientists, Positive Views of Science Continue to Decline

Symptoms, Prevention, and Treatment of Whooping Cough

Whooping cough, also known as pertussis, was a leading cause of childhood illness and death in the United States before the introduction of a vaccine. Millions of people were diagnosed between 1940 and 1945 before seeing a reduction in cases in the 1970s to less than 3,000 per year.

The number of cases of whooping cough in the U.S. in 2024 remains below normal pre-pandemic levels, which typically sit around 20,000 annually. According to the CDC, cases jumped to nearly 50,000 during a 2012 outbreak. During the pandemic, the country saw a steep decline in whooping cough cases, dropping to 6,100 in 2020 and just 2,100 in 2021.

With a rise in whooping cough cases across Europe, Asia, and parts of the United States, health experts want to ensure parents understand the symptoms and how they can prevent this disease from harming their children.

What is Whooping Cough?

Whooping cough, caused by Bordetella pertussis, is mostly found in babies and young children. Still, coughing and sneezing can infect individuals of any age. Even with the vaccine, people can still transmit the disease. Infants under one year are particularly vulnerable, with one-third requiring hospitalization and facing risks like pneumonia, apnea, and dehydration. Older adults, pregnant women, and the immunocompromised are also at high risk for severe complications.

Symptoms of Whooping Cough

The symptoms of whooping cough can be divided into three stages:

1. Catarrhal Stage (1–2 weeks):

● Symptoms resemble a common cold, including a runny nose, sneezing, mild fever, and a mild cough.

● This stage is the most contagious.

2. Paroxysmal Stage (1–6 weeks):

● The sign of this stage is severe, uncontrollable coughing fits followed by a high-pitched “whoop” sound.

● Coughing fits can lead to vomiting, exhaustion, and, in some cases, difficulty breathing.

● Infants might not whoop but may have trouble breathing or even stop breathing briefly.

3. Convalescent Stage (weeks to months):

● Gradual recovery begins, but coughing fits may return if the person contracts another respiratory illness.

How Whooping Cough Transmits

Whooping cough spreads through respiratory droplets when an infected person coughs or sneezes. People are most contagious during the early stage of the illness.

Certain factors increase the risk of contracting whooping cough:

● Unvaccinated individuals are at higher risk of contracting whooping cough.

● Infants under 6 months are particularly vulnerable because they are too young to have received the full course of vaccinations.

● Close contact: Living in the same household or spending extended time with an infected person heightens the risk.

Prevention

Vaccination is the most effective way to prevent whooping cough. The primary vaccines are DTaP for infants and children and Tdap for adolescents, adults, and pregnant women. The vaccination schedule typically includes:

● DTaP vaccine: Given in five doses at 2, 4, and 6 months, between 15–18 months, and between 4–6 years.

● Tdap vaccine: Recommended for preteens (11–12 years), pregnant women during each pregnancy (preferably between 27–36 weeks), and adults who haven’t received it before.

These vaccines have varying degrees of effectiveness and duration of protection. While they generally provide immunity, this protection diminishes over time. Diphtheria vaccines are effective for roughly a decade, while tetanus vaccines offer near-universal protection for a similar duration.

DTaP has been known to protect in the first year after completion, but this reduces over time, with only about 7 in 10 children fully protected five years post-vaccination. Tdap, administered to older individuals, offers slightly lower but still considerable protection, with around 7 in 10 fully protected in the first year and 3 or 4 in 10 after four years.

Studies also demonstrate the effectiveness of Tdap in pregnant women, significantly reducing the risk of whooping cough transmission to newborns. Over three-quarters of infants under two months old are protected from whooping cough, and vaccination prevents nearly all cases requiring hospital treatment.

Treatment

Antibiotics can effectively treat whooping cough and help reduce its spread to others if diagnosed early. Commonly prescribed antibiotics include azithromycin, erythromycin, and clarithromycin. For those with severe symptoms, especially infants, hospitalization may be necessary to monitor and support breathing.

Whooping cough is a preventable but serious disease that can have severe consequences, especially for young children and infants. Vaccination remains the most effective measure to protect against pertussis. Awareness of symptoms and early treatment can help manage and prevent the disease’s spread. With the rise of certain diseases in the United States, it’s important to talk to your healthcare provider about keeping up-to-date on your vaccines.

Sources

CDC: Diphtheria, Tetanus, and Whooping Cough Vaccination

CDC: Pregnancy and Whooping Cough

CDC: Pertussis Cases by Year (1922-2021)

American College of Obstetricians and Gynecologists: The Tdap Vaccine and Pregnancy

Get the latest updates from Health Hero